NASDAQ:FATE
$5.25
(
3.55%
)
Friday, 2nd Jun 2023
Fate Therapeutics Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $4.74 | $6.60 | Friday, 2nd Jun 2023 FATE stock ended at $5.25. This is 3.55% more than the trading day before Thursday, 1st Jun 2023. During the day the stock fluctuated 4.35% from a day low at $5.06 to a day high of $5.28. |
| 90 days | $4.74 | $6.74 | |
| 52 weeks | $4.02 | $37.13 |
Historical Fate Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2023-06-02 | $5.18 | $5.28 | $5.06 | $5.25 | 1 454 288 |
| 2023-06-01 | $5.05 | $5.20 | $4.80 | $5.07 | 1 651 776 |
| 2023-05-31 | $4.96 | $5.26 | $4.90 | $5.05 | 2 027 216 |
| 2023-05-30 | $5.16 | $5.30 | $4.88 | $4.96 | 2 386 915 |
| 2023-05-26 | $5.14 | $5.19 | $5.00 | $5.13 | 1 609 074 |
| 2023-05-25 | $5.34 | $5.34 | $4.99 | $5.04 | 2 260 121 |
| 2023-05-24 | $5.46 | $5.46 | $5.25 | $5.34 | 1 603 749 |
| 2023-05-23 | $5.26 | $5.65 | $5.26 | $5.47 | 1 862 822 |
| 2023-05-22 | $4.97 | $5.33 | $4.95 | $5.23 | 2 253 099 |
| 2023-05-19 | $4.98 | $5.11 | $4.91 | $4.98 | 1 512 955 |
| 2023-05-18 | $5.07 | $4.99 | $4.74 | $4.89 | 1 901 002 |
| 2023-05-17 | $5.02 | $5.10 | $4.82 | $5.03 | 1 693 667 |
| 2023-05-16 | $5.17 | $5.18 | $4.89 | $4.91 | 1 934 197 |
| 2023-05-15 | $5.00 | $5.40 | $4.99 | $5.33 | 2 294 958 |
| 2023-05-12 | $5.28 | $5.28 | $4.90 | $4.97 | 2 018 546 |
| 2023-05-11 | $5.34 | $5.40 | $5.17 | $5.26 | 1 938 258 |
| 2023-05-10 | $5.50 | $5.61 | $5.25 | $5.34 | 2 182 745 |
| 2023-05-09 | $5.37 | $5.59 | $5.29 | $5.39 | 2 049 009 |
| 2023-05-08 | $5.65 | $5.67 | $5.25 | $5.45 | 2 828 272 |
| 2023-05-05 | $6.28 | $6.28 | $5.51 | $5.68 | 3 069 505 |
| 2023-05-04 | $6.00 | $6.60 | $5.58 | $6.17 | 3 326 802 |
| 2023-05-03 | $5.88 | $6.48 | $5.86 | $6.32 | 2 930 044 |
| 2023-05-02 | $6.32 | $6.32 | $5.72 | $5.92 | 3 595 616 |
| 2023-05-01 | $6.10 | $6.47 | $6.08 | $6.36 | 2 529 747 |
| 2023-04-28 | $5.86 | $6.11 | $5.72 | $6.07 | 2 080 988 |
| 2023-04-27 | $5.88 | $6.03 | $5.71 | $5.84 | 1 933 752 |
| 2023-04-26 | $6.03 | $6.12 | $5.78 | $5.82 | 1 597 198 |
| 2023-04-25 | $6.25 | $6.46 | $5.97 | $6.03 | 2 033 308 |
| 2023-04-24 | $6.36 | $6.40 | $6.12 | $6.34 | 1 410 516 |
| 2023-04-21 | $6.03 | $6.23 | $5.99 | $6.22 | 2 066 141 |
| 2023-04-20 | $6.34 | $6.35 | $5.96 | $6.00 | 2 095 534 |
| 2023-04-19 | $6.23 | $6.52 | $6.14 | $6.36 | 1 414 340 |
| 2023-04-18 | $6.73 | $6.74 | $6.16 | $6.23 | 2 601 123 |
| 2023-04-17 | $6.08 | $6.66 | $6.07 | $6.59 | 2 763 934 |
| 2023-04-14 | $5.84 | $6.22 | $5.80 | $6.01 | 10 498 333 |
| 2023-04-13 | $5.76 | $6.29 | $5.64 | $6.20 | 3 671 343 |
| 2023-04-12 | $5.62 | $5.90 | $5.56 | $5.61 | 2 236 187 |
| 2023-04-11 | $5.52 | $5.71 | $5.47 | $5.64 | 1 570 936 |
| 2023-04-10 | $5.81 | $5.81 | $5.45 | $5.48 | 2 361 929 |
| 2023-04-06 | $5.52 | $5.89 | $5.44 | $5.85 | 2 118 153 |
| 2023-04-05 | $5.50 | $5.65 | $5.46 | $5.50 | 1 137 559 |
| 2023-04-04 | $5.72 | $5.89 | $5.44 | $5.53 | 1 799 429 |
| 2023-04-03 | $5.59 | $5.89 | $5.56 | $5.81 | 1 763 415 |
| 2023-03-31 | $5.38 | $5.73 | $5.29 | $5.70 | 1 814 027 |
| 2023-03-30 | $5.61 | $5.66 | $5.28 | $5.30 | 1 721 720 |
| 2023-03-29 | $5.35 | $5.58 | $5.25 | $5.55 | 2 049 203 |
| 2023-03-28 | $5.45 | $5.47 | $5.26 | $5.27 | 1 693 367 |
| 2023-03-27 | $5.37 | $5.62 | $5.34 | $5.48 | 2 123 649 |
| 2023-03-24 | $5.19 | $5.43 | $5.05 | $5.39 | 1 708 975 |
| 2023-03-23 | $5.33 | $5.36 | $5.08 | $5.23 | 2 140 273 |
About Fate Therapeutics
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... FATE Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
